Target intelligence / Profile preview

Zinc finger DHHC-type containing protein 11B (ZDHHC11B)

Target
ZDHHC11B
Molecular classification
Enzyme, Protein S-acyltransferase, Zinc finger protein
01

Overview

Zinc finger DHHC-type containing protein 11B (ZDHHC11B) is a protein-coding gene that encodes a probable S-palmitoyltransferase enzyme, predicted to catalyze the post-translational modification of proteins via S-acylation (the addition of palmitate to protein cysteine residues)[2][3][5]. ZDHHC11B belongs to the DHHC (Asp-His-His-Cys) domain-containing zinc finger protein family, which regulates diverse cellular processes through controlling protein localization and function via palmitoylation. ZDHHC11B is localized to the Golgi apparatus, endoplasmic reticulum, and endosome membranes[2]. Recent research implicates ZDHHC11B as a tumor suppressor in lung adenocarcinoma: decreased expression in tumor tissue correlates with worse patient prognosis and increased tumor cell proliferation, migration, and invasion, mediated at least in part by suppression of EMT signaling pathways[1]. While it is not currently a direct therapeutic target of approved drugs, its expression and function in critical signaling pathways highlight its relevance in cancer biology and its potential as a future biomarker or target[1][2][5].

Other names
Probable palmitoyltransferase ZDHHC11BDHHC-11BZinc finger DHHC domain-containing protein 11BZDHHC11Bputative palmitoyltransferase ZDHHC11B
02

Mechanism of action

No drugs are known to directly target ZDHHC11B; however, modulation of its enzyme activity would alter palmitoylation status of substrate proteins, affecting downstream cellular functions, including proliferative signaling and metastasis[1][2][3][5].

03

Biological functions

Protein palmitoylation (S-acylation, a post-translational lipid modification)Regulation of protein localization and functionRegulation of epithelial–mesenchymal transition (EMT)Regulation of cell proliferation, migration, invasion, apoptosisInvolvement in antiviral innate immune response
04

Disease associations

Cancer (notably acts as a tumor suppressor in lung adenocarcinoma)Possible involvement in bone squamous cell carcinoma
05

Safety considerations

No known drug-related safety concerns as there are no clinically approved drugs that specifically target ZDHHC11B[2][5].
06

Biomarkers

Expression level of ZDHHC11B as a prognostic biomarker in lung adenocarcinoma (low expression correlates with poor prognosis[1])

Beyond the preview

Go deeper on Zinc finger DHHC-type containing protein 11B (ZDHHC11B).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zinc finger DHHC-type containing protein 11B (ZDHHC11B).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call